Rowland & Company Investment Counsel Increased Fluor (FLR) Position; Historic Lifepoint Hospitals Has 0.82 Sentiment

May 21, 2018 - By Adrian Mccoy

LifePoint Health, Inc. (NASDAQ:LPNT) Logo

Historic Lifepoint Hospitals Inc (LPNT) investors sentiment decreased to 0.82 in 2017 Q4. It’s down -0.48, from 1.3 in 2017Q3. The ratio turned negative, as 84 funds opened new and increased holdings, while 103 sold and trimmed equity positions in Historic Lifepoint Hospitals Inc. The funds in our database now own: 40.34 million shares, down from 40.50 million shares in 2017Q3. Also, the number of funds holding Historic Lifepoint Hospitals Inc in top ten holdings was flat from 0 to 0 for the same number . Sold All: 32 Reduced: 71 Increased: 58 New Position: 26.

Rowland & Company Investment Counsel increased Fluor Corporation (FLR) stake by 44.53% reported in 2017Q4 SEC filing. Rowland & Company Investment Counsel acquired 3,460 shares as Fluor Corporation (FLR)’s stock rose 9.18%. The Rowland & Company Investment Counsel holds 11,230 shares with $582.07 million value, up from 7,770 last quarter. Fluor Corporation now has $7.02B valuation. The stock increased 0.24% or $0.12 during the last trading session, reaching $49.9. About 2.37M shares traded or 44.17% up from the average. Fluor Corporation (NYSE:FLR) has risen 8.50% since May 21, 2017 and is uptrending. It has underperformed by 3.05% the S&P500.

More recent Fluor Corporation (NYSE:FLR) news were published by: which released: “Oregon’s small-nuke company wins $40M federal grant” on April 27, 2018. Also published the news titled: “Fluor Corporation 2018 Q1 – Results – Earnings Call Slides” on May 04, 2018.‘s news article titled: “NuScale Power clears hurdle in nuclear design safety review” with publication date: April 30, 2018 was also an interesting one.

Since February 23, 2018, it had 1 insider purchase, and 10 insider sales for $5.15 million activity. Flowers Garry William sold $224,320 worth of stock. The insider BARNARD RAY F. sold 3,893 shares worth $223,636. Seaton David Thomas also sold $2.84 million worth of Fluor Corporation (NYSE:FLR) shares. $222,942 worth of Fluor Corporation (NYSE:FLR) was sold by Bustamante Jose Luis M.. Shares for $1.76 million were sold by HERNANDEZ CARLOS M. $205,089 worth of stock was sold by De Haan Taco on Friday, March 9. Stanski Bruce A sold 3,718 shares worth $213,547.

Among 22 analysts covering Fluor Corporation (NYSE:FLR), 9 have Buy rating, 0 Sell and 13 Hold. Therefore 41% are positive. Fluor Corporation has $9000 highest and $40.0 lowest target. $56.05’s average target is 12.32% above currents $49.9 stock price. Fluor Corporation had 67 analyst reports since July 31, 2015 according to SRatingsIntel. The company was upgraded on Friday, December 9 by Citigroup. On Tuesday, December 12 the stock rating was initiated by Barclays Capital with “Hold”. Deutsche Bank maintained Fluor Corporation (NYSE:FLR) rating on Friday, July 31. Deutsche Bank has “Hold” rating and $52 target. As per Friday, November 4, the company rating was downgraded by Johnson Rice. The rating was maintained by Canaccord Genuity with “Buy” on Monday, July 31. The stock of Fluor Corporation (NYSE:FLR) has “Outperform” rating given on Friday, February 19 by Macquarie Research. Barclays Capital maintained Fluor Corporation (NYSE:FLR) on Wednesday, January 24 with “Equal-Weight” rating. As per Friday, November 13, the company rating was initiated by Citigroup. The stock has “Hold” rating by Robert W. Baird on Friday, May 4. The stock of Fluor Corporation (NYSE:FLR) has “Market Perform” rating given on Friday, February 19 by FBR Capital.

Investors sentiment increased to 0.83 in 2017 Q4. Its up 0.02, from 0.81 in 2017Q3. It increased, as 48 investors sold FLR shares while 150 reduced holdings. 60 funds opened positions while 104 raised stakes. 118.31 million shares or 2.82% more from 115.07 million shares in 2017Q3 were reported. M&T State Bank reported 10,589 shares. Hotchkis And Wiley Cap Mgmt Lc holds 1.87M shares. Jpmorgan Chase holds 0% of its portfolio in Fluor Corporation (NYSE:FLR) for 436,815 shares. Estabrook owns 0.01% invested in Fluor Corporation (NYSE:FLR) for 665 shares. Needelman Asset Management Incorporated holds 2.73% in Fluor Corporation (NYSE:FLR) or 21,115 shares. Profund Advisors Limited Liability Corporation holds 4,504 shares. Huber Limited Com reported 89,202 shares or 0.25% of all its holdings. Minnesota-based Thrivent Financial For Lutherans has invested 0% in Fluor Corporation (NYSE:FLR). State Of Wisconsin Inv Board invested in 89,984 shares. New Jersey-based Bessemer Group has invested 0% in Fluor Corporation (NYSE:FLR). Citigroup, a New York-based fund reported 193,623 shares. Guggenheim Cap Limited Liability Corp accumulated 0.14% or 1.18 million shares. 99,805 were accumulated by Parsec Fincl Mgmt. The Ontario – Canada-based Intact Inv Mngmt has invested 0.01% in Fluor Corporation (NYSE:FLR). Ci Investments, Ontario – Canada-based fund reported 874,544 shares.

Rowland & Company Investment Counsel decreased Cullen Frost Bankers (NYSE:CFR) stake by 913 shares to 50,597 valued at $4.79 billion in 2017Q4. It also reduced Cintas Corp (NASDAQ:CTAS) stake by 35 shares and now owns 5,178 shares. United Technologies (NYSE:UTX) was reduced too.

LifePoint Health, Inc., through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. The company has market cap of $2.14 billion. The Company’s hospitals offer a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric services, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery. It has a 22.01 P/E ratio. The companyÂ’s hospitals also provide various outpatient services comprising same-day surgery, laboratory, X-ray, respiratory therapy, imaging, sports medicine, and lithotripsy.

More recent LifePoint Health, Inc. (NASDAQ:LPNT) news were published by: which released: “LifePoint Health (LPNT) Q1 2018 Results – Earnings Call Transcript” on May 04, 2018. Also published the news titled: “Report: Exploring Fundamental Drivers Behind Reliance Steel & Aluminum, Goldman Sachs BDC, IBERIABANK …” on May 04, 2018.‘s news article titled: “Earnings Scheduled For May 4, 2018” with publication date: May 04, 2018 was also an interesting one.

Profit Investment Management Llc holds 1.65% of its portfolio in LifePoint Health, Inc. for 43,304 shares. Dean Capital Management owns 54,438 shares or 1.28% of their US portfolio. Moreover, Sivik Global Healthcare Llc has 1.02% invested in the company for 55,000 shares. The New York-based New Amsterdam Partners Llc Ny has invested 0.97% in the stock. Smith Graham & Co. Investment Advisors Lp, a Texas-based fund reported 205,780 shares.

Analysts await LifePoint Health, Inc. (NASDAQ:LPNT) to report earnings on August, 7. They expect $1.08 earnings per share, up 12.50% or $0.12 from last year’s $0.96 per share. LPNT’s profit will be $41.89 million for 12.79 P/E if the $1.08 EPS becomes a reality. After $1.22 actual earnings per share reported by LifePoint Health, Inc. for the previous quarter, Wall Street now forecasts -11.48% negative EPS growth.

The stock decreased 0.18% or $0.1 during the last trading session, reaching $55.25. About 331,328 shares traded. LifePoint Health, Inc. (LPNT) has declined 25.67% since May 21, 2017 and is downtrending. It has underperformed by 37.22% the S&P500.

LifePoint Health, Inc. (NASDAQ:LPNT) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: